Mölnlycke Health Care is a Swedish medical-technology group (Gothenburg HQ; ~8,500 employees globally) specialising in wound care, single-use surgical products, surgical gloves and antiseptics. The company runs a Portuguese subsidiary, Mölnlycke Health Care Lda., headquartered in Matosinhos with a regional sales structure that covers Portugal and Western Spain.
Mölnlycke Health Care’s Portuguese commercial footprint is anchored by Mölnlycke Health Care Lda., the local subsidiary registered in Matosinhos. The company sells wound care lines (Mepilex, Mepore, Mextra, Tubifast), single-use surgical drapes and gowns under the BARRIER brand, and surgical gloves under Biogel into Portuguese hospital tender channels and specialised distribution. The Portugal market is operated as part of the Iberia commercial cluster, with a single regional sales structure covering Portugal and Western Spain — reflecting how multinational med-tech companies typically run the peninsula as one logistics and key-account region.
For Portuguese hospitals, Mölnlycke is one of the most-used Nordic-owned suppliers in pressure-injury prevention and surgical drape categories. The brand’s long-standing presence in the European med-tech landscape, the Wallenberg-sphere ownership through Investor AB, and the consistency of the assortment across countries make it a structural component of Portuguese hospital procurement.
Mölnlycke is one of the largest Nordic-owned med-tech footprints in Portugal. As Portuguese SNS hospitals and the private hospital groups continue to invest in surgical capacity and chronic-wound management, demand for the Mölnlycke product portfolio is structurally supported. For Nordic med-tech companies considering the Portuguese market, the Mölnlycke playbook of a registered local entity coupled with an Iberia cluster sales structure is one of the most replicated approaches in the corridor.
Fractio helps Nordic companies enter the Portuguese market — from market sizing to first sales, hiring, and legal setup.
Talk to Fractio →